Free PHQ-2 Depression Screening Calculator

The PHQ-2 (Patient Health Questionnaire‑2) is a widely validated, ultra‑brief depression screening tool designed for both clinical settings and self‑assessment. By asking just two targeted questions, this depression test can be completed in under 30 seconds, making it an efficient first step in depression assessment. Its brevity does not compromise its reliability; research published in the journal Medical Care has confirmed the PHQ‑2’s validity as a depression screener.

Understanding Depression: Core Features and Related Conditions

Depression encompasses several depressive disorders, all characterized by persistent feelings of sadness, emptiness, or irritability, accompanied by cognitive and somatic changes that disrupt daily functioning. The duration, timing, and triggers distinguish the various types. Major depressive disorder (MDD) is the most common form; its diagnosis requires at least two weeks of symptoms such as markedly diminished interest or pleasure (anhedonia), significant weight or appetite changes, sleep difficulties, psychomotor changes, fatigue, inappropriate guilt, poor concentration, and recurrent thoughts of death or suicide. These symptoms must cause clinically significant distress or impairment and not be attributable to substance use or another medical condition.

Several medical conditions are known to mimic or coexist with depressive mood, including hypothyroidism, Addison’s disease, Cushing’s disease, multiple sclerosis, brain tumors, HIV/AIDS, cancer, rheumatoid arthritis, systemic lupus erythematosus, and other psychiatric disorders or addictions. Recognizing these possibilities is important for accurate diagnosis.

The Case for Routine Screening

Depression is one of the leading causes of disability worldwide, affecting approximately 1 in 15 adults (6.7%) annually and 1 in 6 people (16.6%) over a lifetime. The World Health Organization estimates that over 350 million individuals globally live with depression. Its recurrent nature and profound impact on quality of life underscore the value of periodic screening, as recommended by the U.S. Preventive Services Task Force. Tools like the PHQ‑2 enable quick identification of individuals who may benefit from a more comprehensive evaluation.

How the PHQ‑2 Screening Tool Works

The PHQ‑2 asks two questions about the frequency of depressive symptoms over the past two weeks:

1. “Little interest or pleasure in doing things” (anhedonia)
2. “Feeling down, depressed, or hopeless”

Each item is scored from 0 (not at all) to 3 (nearly every day), producing a total PHQ‑2 score ranging from 0 to 6. Higher scores indicate greater risk. Studies have associated each score with a positive predictive value (PPV) and likelihood ratio (LR) for major depressive disorder and any depressive disorder, as shown in the table below:

PHQ‑2 Score	Major Depressive Disorder		Any Depressive Disorder
	PPV (%)	LR	PPV (%)	LR
1	15.4	0.3	36.9	0.6
2	21.1	0.6	48.3	1.3
3	38.4	2.9	75.0	5.4
4	45.4	5.5	81.2	15.7
5	56.4	10.3	84.6	17.9
6	78.6	48.2	92.9	58.1

A score of 3 or more is generally considered a positive screen, warranting further assessment by a mental health professional.

Interpreting the Results: PPV and Likelihood Ratios

The positive predictive value (PPV) indicates the probability that an individual with a given score actually has the disorder. It can be expressed as:

$$\text{PPV} = \frac{\text{true positives}}{\text{true positives} + \text{false positives}}$$

The likelihood ratio (LR) compares the odds of obtaining a particular score in someone with the disorder versus someone without. For a positive test, the LR is calculated as:

$$\text{LR} = \frac{\text{sensitivity}}{1 - \text{specificity}}$$

An LR greater than 1 increases the probability of the disorder; an LR less than 1 decreases it. For example, a PHQ‑2 score of 4 yields an LR of 5.5 for major depression, meaning the patient is about 5.5 times more likely to have MDD compared to the general population.

Using the Calculator: A Practical Example

Consider a person who reports experiencing “little interest or pleasure” on several days (score = 1) and feeling “down, depressed, or hopeless” nearly every day (score = 3). Their total PHQ‑2 score is 4. According to the table, this corresponds to a PPV of 45.4% for major depression and 81.2% for any depressive disorder, with LRs of 5.5 and 15.7 respectively. These values indicate a substantially elevated risk, and a referral to a clinical psychologist is strongly recommended.

Limitations and Next Steps

The PHQ‑2 is a screening instrument, not a diagnostic tool. It does not capture the full spectrum of depressive symptoms and may yield false‑positive results, especially in individuals with medical conditions or substance use that mimic depression. A positive screen should always be followed by a comprehensive clinical interview, such as the PHQ‑9 or a structured diagnostic assessment.

If you or someone you know screens positive or is experiencing symptoms, seeking help from a licensed mental health provider is crucial. Effective treatments exist, including cognitive‑behavioral therapy (CBT), counseling, and medication (antidepressants). Adopting healthy lifestyle habits—such as improving sleep hygiene, regular physical activity, a balanced diet, mindfulness practice, and building a strong support network—can also support recovery, but these measures complement rather than replace professional care.

Remember: early detection through screening like the PHQ‑2 can be the first step toward effective treatment and improved quality of life.